Fischer Medical Ventures Limited has allotted 10,50,000 equity shares upon conversion of convertible warrants issued on a preferential basis to non-promoter public category.
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures has allotted 10,50,000 equity shares (face value Rs. 10 each) at an issue price of Rs. 33.20 per share, including a premium of Rs. 23.20. These shares were issued upon conversion of convertible warrants that were originally allotted on a preferential basis to non-promoter investors. The total consideration received is approximately Rs. 3.49 crore, representing the remaining 75% of the warrant exercise price (25% was paid earlier at the time of warrant issuance). The shares were allotted to three non-promoter allottees: Crishi Sanjay Jain (4.5 lakh shares), Nikita Sanjay Jain (4.5 lakh shares), and Vikasa India EIF I Fund (1.5 lakh shares). The Board approved this through a circular resolution dated 9th April 2025.
This is a warrant-to-equity conversion event, not new fundraising, as the 25% upfront money was already paid earlier. Existing shareholders will see a marginal dilution of about 10.5 lakh new shares entering the market. The stock may see short-term pressure if allottees decide to sell after the mandatory lock-in period.